Annexon, Inc.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets disti…
Biotechnology
US, Brisbane [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Annexon, Inc. (ANNX) to it's peer group.
Peer Group
BPMC KRTX ISEE GPCR CGEM RLAY AMLX ZURA AVRO XFOR DAWN HEPA INAB IMMX ICVX CNSP INZY ABOS RCUS
Compare Together
Loading...